Financial reports
10-Q
2024 Q3
Quarterly report
13 Nov 24
10-Q
2024 Q2
Quarterly report
13 Aug 24
ARS
2023 FY
Annual report to shareholders
28 May 24
10-Q
2024 Q1
Quarterly report
14 May 24
10-K/A
2023 FY
Annual report (amended)
17 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
31 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
Current reports
8-K
Entry into a Material Definitive Agreement
27 Feb 25
8-K
Entry into a Material Definitive Agreement
20 Feb 25
8-K
Entry into a Material Definitive Agreement
3 Feb 25
8-K
Entry into a Material Definitive Agreement
13 Nov 24
8-K
Jaguar Health Reports Third Quarter 2024 Financial Results
13 Nov 24
8-K
Jaguar Health Reports Second Quarter 2024 Financial Results
13 Aug 24
8-K
Jaguar Health Reports Phase 3 OnTarget Trial Results for its
23 Jul 24
8-K
Entry into a Material Definitive Agreement
18 Jul 24
8-K
Unregistered Sales of Equity Securities
16 Jul 24
8-K
Other Events
26 Jun 24
Registration and prospectus
8-A12B
Registration of securities on exchange
27 Feb 25
424B5
Prospectus supplement for primary offering
13 Nov 24
S-8
Registration of securities for employees
13 Aug 24
424B5
Prospectus supplement for primary offering
17 Jul 24
424B5
Prospectus supplement for primary offering
23 May 24
424B3
Prospectus supplement
1 May 24
S-3
Shelf registration
22 Apr 24
424B5
Prospectus supplement for primary offering
2 Apr 24
S-8
Registration of securities for employees
1 Apr 24
D
$60.00 k in equity / Common Stock, sold $60.00 k, 1 investor
30 Nov 23
Proxies
DEF 14A
Definitive proxy
24 Feb 25
PRE 14A
Preliminary proxy
14 Feb 25
DEFA14A
Additional proxy soliciting materials
31 May 24
DEF 14A
Definitive proxy
21 May 24
PRE 14A
Preliminary proxy
10 May 24
DEF 14A
Definitive proxy
15 Mar 24
PRE 14A
Preliminary proxy
5 Mar 24
DEF 14A
Definitive proxy
31 May 23
PRE 14A
Preliminary proxy
16 May 23
DEFR14A
Revised proxy
15 Dec 22
Other
EFFECT
Notice of effectiveness
2 May 24
EFFECT
Notice of effectiveness
6 Dec 21
CORRESP
Correspondence with SEC
1 Dec 21
UPLOAD
Letter from SEC
30 Nov 21
EFFECT
Notice of effectiveness
10 Jun 21
CORRESP
Correspondence with SEC
7 Jun 21
UPLOAD
Letter from SEC
4 Jun 21
EFFECT
Notice of effectiveness
24 Sep 20
CORRESP
Correspondence with SEC
21 Sep 20
UPLOAD
Letter from SEC
18 Sep 20
Ownership